| GO(Gene Ontology) name | FDR corrected p-value |
|---|
| developmental process (GO:0032502) | 0 |
| cell part (GO:0044464) | 0 |
| multicellular organismal process (GO:0032501) | 0 |
| multicellular organismal development (GO:0007275) | 0 |
| intracellular part (GO:0044424) | 0 |
| system development (GO:0048731) | 0 |
| cytoplasm (GO:0005737) | 0 |
| anatomical structure development (GO:0048856) | 0 |
| protein binding (GO:0005515) | 0 |
| organ development (GO:0048513) | 5.90284624057522e-84 |
| membrane-bound organelle (GO:0043227) | 4.4989053553e-77 |
| intracellular membrane-bound organelle (GO:0043231) | 7.33751105644226e-77 |
| anatomical structure morphogenesis (GO:0009653) | 1.84126141997054e-74 |
| intracellular (GO:0005622) | 1.32027925664946e-73 |
| organelle (GO:0043226) | 1.35868956601407e-72 |
| intracellular organelle (GO:0043229) | 4.01857451463154e-72 |
| biological regulation (GO:0065007) | 1.84369300911352e-65 |
| membrane (GO:0016020) | 1.00477095616639e-64 |
| plasma membrane part (GO:0044459) | 3.14335163614853e-64 |
| plasma membrane (GO:0005886) | 2.79942930764888e-62 |
| nervous system development (GO:0007399) | 4.43616121236848e-62 |
| membrane part (GO:0044425) | 8.7070747681476e-60 |
| regulation of biological process (GO:0050789) | 3.9806008993317e-58 |
| cell junction (GO:0030054) | 4.4340827412832e-50 |
| intrinsic to plasma membrane (GO:0031226) | 4.21995140602509e-49 |
| integral to plasma membrane (GO:0005887) | 5.46843340007539e-48 |
| cellular developmental process (GO:0048869) | 2.93140898738263e-47 |
| cell differentiation (GO:0030154) | 2.93140898738263e-47 |
| regulation of cellular process (GO:0050794) | 8.87757959648915e-46 |
| intrinsic to membrane (GO:0031224) | 1.42276336482556e-44 |
| integral to membrane (GO:0016021) | 2.22774621068434e-44 |
| cellular component organization and biogenesis (GO:0016043) | 5.67083967967062e-43 |
| cell communication (GO:0007154) | 8.26228391420526e-41 |
| cell morphogenesis (GO:0000902) | 5.98705550820449e-38 |
| cellular structure morphogenesis (GO:0032989) | 5.98705550820449e-38 |
| cell-cell signaling (GO:0007267) | 1.68055877596221e-37 |
| negative regulation of cellular process (GO:0048523) | 1.3604704339693e-35 |
| localization (GO:0051179) | 1.08287920250296e-34 |
| negative regulation of biological process (GO:0048519) | 2.39534287395454e-34 |
| cell projection (GO:0042995) | 3.69408048181882e-34 |
| Golgi apparatus (GO:0005794) | 1.47332481338714e-32 |
| organ morphogenesis (GO:0009887) | 3.04863341454077e-32 |
| biological adhesion (GO:0022610) | 9.93146869987115e-32 |
| cell adhesion (GO:0007155) | 9.93146869987115e-32 |
| cell proliferation (GO:0008283) | 6.9210037063253e-31 |
| skeletal development (GO:0001501) | 1.01677150582785e-30 |
| transmission of nerve impulse (GO:0019226) | 6.50127676133695e-30 |
| nucleus (GO:0005634) | 2.0547151112593e-29 |
| synaptic transmission (GO:0007268) | 4.65810907733518e-29 |
| cell development (GO:0048468) | 5.66733894303302e-29 |
| signal transduction (GO:0007165) | 1.99768245044749e-28 |
| enzyme linked receptor protein signaling pathway (GO:0007167) | 3.003535086553e-28 |
| cell fraction (GO:0000267) | 3.37743307750393e-28 |
| neurogenesis (GO:0022008) | 3.71994129287113e-28 |
| membrane fraction (GO:0005624) | 1.32891046643413e-27 |
| muscle development (GO:0007517) | 1.32891046643413e-27 |
| positive regulation of biological process (GO:0048518) | 2.81768297843335e-27 |
| proteinaceous extracellular matrix (GO:0005578) | 6.71639740128458e-27 |
| transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169) | 7.37393046749096e-27 |
| generation of neurons (GO:0048699) | 8.94441772234665e-27 |
| cytoplasmic part (GO:0044444) | 1.0383474464518e-26 |
| extracellular region part (GO:0044421) | 1.90869022874755e-26 |
| transcription factor binding (GO:0008134) | 2.7341408380363e-26 |
| intracellular signaling cascade (GO:0007242) | 9.76321432991129e-26 |
| cytoskeleton (GO:0005856) | 4.60040531418798e-25 |
| transcription from RNA polymerase II promoter (GO:0006366) | 1.72668089175916e-24 |
| organelle membrane (GO:0031090) | 4.43917141345185e-23 |
| localization of cell (GO:0051674) | 6.93608010529704e-23 |
| cell motility (GO:0006928) | 6.93608010529704e-23 |
| endomembrane system (GO:0012505) | 6.93608010529704e-23 |
| intracellular organelle part (GO:0044446) | 7.10073067778054e-23 |
| organelle part (GO:0044422) | 7.21822114204998e-23 |
| embryonic development (GO:0009790) | 7.51127749096601e-23 |
| central nervous system development (GO:0007417) | 7.51127749096601e-23 |
| establishment of localization (GO:0051234) | 9.54068826099028e-23 |
| transcription repressor activity (GO:0016564) | 1.1318499032481e-22 |
| positive regulation of cellular process (GO:0048522) | 3.10518451244827e-22 |
| transport (GO:0006810) | 7.70273315027066e-22 |
| cell projection organization and biogenesis (GO:0030030) | 1.94469971185637e-21 |
| cell projection morphogenesis (GO:0048858) | 1.94469971185637e-21 |
| cell part morphogenesis (GO:0032990) | 1.94469971185637e-21 |
| neuron differentiation (GO:0030182) | 2.4461198226207e-21 |
| alkali metal ion binding (GO:0031420) | 3.61672648734552e-21 |
| regulation of metabolic process (GO:0019222) | 4.29037657667084e-21 |
| cytoskeletal protein binding (GO:0008092) | 6.38829716128326e-21 |
| neuron development (GO:0048666) | 6.94556237561274e-21 |
| actin cytoskeleton organization and biogenesis (GO:0030036) | 8.74486050578455e-21 |
| protein kinase cascade (GO:0007243) | 1.16334410099726e-20 |
| actin filament-based process (GO:0030029) | 1.43658165443652e-20 |
| vasculature development (GO:0001944) | 1.67485862105936e-20 |
| Golgi membrane (GO:0000139) | 1.86176525194816e-20 |
| cell migration (GO:0016477) | 2.94747730749743e-20 |
| intercellular junction (GO:0005911) | 3.93730936301634e-20 |
| Golgi apparatus part (GO:0044431) | 4.18543711401402e-20 |
| blood vessel development (GO:0001568) | 8.360390955653e-20 |
| transcription cofactor activity (GO:0003712) | 1.04161446622604e-19 |
| brain development (GO:0007420) | 1.16654636777797e-19 |
| ion binding (GO:0043167) | 1.28195991649193e-19 |
| striated muscle development (GO:0014706) | 2.10794672805898e-19 |
| regulation of transcription from RNA polymerase II promoter (GO:0006357) | 4.42343744981724e-19 |
| identical protein binding (GO:0042802) | 4.62474344515706e-19 |
| potassium ion binding (GO:0030955) | 6.03044427639905e-19 |
| regulation of transcription, DNA-dependent (GO:0006355) | 6.76541256461428e-19 |
| pattern specification process (GO:0007389) | 1.96939253463153e-18 |
| regulation of cellular metabolic process (GO:0031323) | 2.39873756525171e-18 |
| vesicle-mediated transport (GO:0016192) | 2.45372803965835e-18 |
| neurite development (GO:0031175) | 3.35144279432141e-18 |
| transcription, DNA-dependent (GO:0006351) | 5.35279402623808e-18 |
| RNA biosynthetic process (GO:0032774) | 7.21236702398149e-18 |
| regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process (GO:0019219) | 7.67246148841888e-18 |
| tissue development (GO:0009888) | 1.04498356012346e-17 |
| regulation of transcription (GO:0045449) | 1.22228834606795e-17 |
| metal ion binding (GO:0046872) | 1.33936274969746e-17 |
| regulation of gene expression (GO:0010468) | 2.88350936804958e-17 |
| neuron projection (GO:0043005) | 2.88350936804958e-17 |
| cellular morphogenesis during differentiation (GO:0000904) | 9.98409682604418e-17 |
| negative regulation of transcription, DNA-dependent (GO:0045892) | 1.14718102555173e-16 |
| actin cytoskeleton (GO:0015629) | 1.80626457367198e-16 |
| cytoskeleton organization and biogenesis (GO:0007010) | 2.63659997550578e-16 |
| vesicle (GO:0031982) | 3.25406067606712e-16 |
| regulation of developmental process (GO:0050793) | 3.56841437962829e-16 |
| MAPKKK cascade (GO:0000165) | 4.19567879687278e-16 |
| regulation of cell proliferation (GO:0042127) | 4.74675654543819e-16 |
| skeletal muscle development (GO:0007519) | 4.83448370324274e-16 |
| transcription (GO:0006350) | 6.29993164546115e-16 |
| neuron morphogenesis during differentiation (GO:0048667) | 9.22626971231994e-16 |
| neurite morphogenesis (GO:0048812) | 9.22626971231994e-16 |
| extracellular matrix part (GO:0044420) | 1.25931076583301e-15 |
| cytoplasmic vesicle (GO:0031410) | 1.33240240773388e-15 |
| protein binding, bridging (GO:0030674) | 1.33486382646819e-15 |
| negative regulation of transcription (GO:0016481) | 1.46542907950553e-15 |
| regulation of neurotransmitter levels (GO:0001505) | 2.5981820756895e-15 |
| transcription corepressor activity (GO:0003714) | 3.03965511865139e-15 |
| transcription factor activity (GO:0003700) | 4.02107647349598e-15 |
| negative regulation of metabolic process (GO:0009892) | 1.22385499996517e-14 |
| blood vessel morphogenesis (GO:0048514) | 1.36800593316141e-14 |
| negative regulation of transcription from RNA polymerase II promoter (GO:0000122) | 3.07801536942747e-14 |
| sequence-specific DNA binding (GO:0043565) | 3.76862513351296e-14 |
| cation binding (GO:0043169) | 8.70533721498267e-14 |
| secretion (GO:0046903) | 1.24479043147105e-13 |
| potassium channel activity (GO:0005267) | 1.89807533433097e-13 |
| voltage-gated potassium channel activity (GO:0005249) | 1.95474293581066e-13 |
| regulation of growth (GO:0040008) | 2.0571527605089e-13 |
| membrane-bound vesicle (GO:0031988) | 2.21577613977263e-13 |
| GPI anchor binding (GO:0048503) | 2.29284348931356e-13 |
| system process (GO:0003008) | 2.5000849694349e-13 |
| negative regulation of cellular metabolic process (GO:0031324) | 2.70552017020727e-13 |
| basolateral plasma membrane (GO:0016323) | 2.73774732861565e-13 |
| negative regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process (GO:0045934) | 2.88173038695927e-13 |
| cytoplasmic membrane-bound vesicle (GO:0016023) | 3.23533446929434e-13 |
| biopolymer metabolic process (GO:0043283) | 5.83684711622608e-13 |
| regulation of cell size (GO:0008361) | 9.34534660416241e-13 |
| actin binding (GO:0003779) | 9.44831678720816e-13 |
| post-translational protein modification (GO:0043687) | 1.09578744521866e-12 |
| apical junction complex (GO:0043296) | 1.27374447390419e-12 |
| cell-substrate adhesion (GO:0031589) | 1.27374447390419e-12 |
| axonogenesis (GO:0007409) | 1.52620363235456e-12 |
| cell-matrix adhesion (GO:0007160) | 2.35151781797163e-12 |
| heart development (GO:0007507) | 2.5599681531521e-12 |
| gated channel activity (GO:0022836) | 3.22150822357943e-12 |
| apicolateral plasma membrane (GO:0016327) | 3.36414437247548e-12 |
| transmembrane receptor protein kinase activity (GO:0019199) | 3.64341354495536e-12 |
| regulation of cell growth (GO:0001558) | 4.13340542995918e-12 |
| embryonic development ending in birth or egg hatching (GO:0009792) | 4.21941123945543e-12 |
| chordate embryonic development (GO:0043009) | 4.21941123945543e-12 |
| lipid binding (GO:0008289) | 6.57624435403214e-12 |
| regulation of biological quality (GO:0065008) | 6.78547277674836e-12 |
| voltage-gated potassium channel complex (GO:0008076) | 6.91986370222351e-12 |
| cell growth (GO:0016049) | 8.13652198937716e-12 |
| calmodulin binding (GO:0005516) | 9.96486474108297e-12 |
| anatomical structure formation (GO:0048646) | 1.09846258558964e-11 |
| protein modification process (GO:0006464) | 1.19194269888458e-11 |
| voltage-gated channel activity (GO:0022832) | 1.22870608183493e-11 |
| voltage-gated ion channel activity (GO:0005244) | 1.22870608183493e-11 |
| regionalization (GO:0003002) | 1.37288045426401e-11 |
| potassium ion transport (GO:0006813) | 1.7280971014059e-11 |
| endoplasmic reticulum (GO:0005783) | 2.19596587832091e-11 |
| stress-activated protein kinase signaling pathway (GO:0031098) | 2.23107602045618e-11 |
| biopolymer modification (GO:0043412) | 4.13893501196273e-11 |
| basement membrane (GO:0005604) | 4.4734517714388e-11 |
| RNA metabolic process (GO:0016070) | 4.82062954807783e-11 |
| microtubule cytoskeleton (GO:0015630) | 5.66871588935408e-11 |
| voltage-gated cation channel activity (GO:0022843) | 6.56791117508726e-11 |
| JNK cascade (GO:0007254) | 7.00386070791265e-11 |
| generation of a signal involved in cell-cell signaling (GO:0003001) | 7.62310399740959e-11 |
| muscle contraction (GO:0006936) | 7.62310399740959e-11 |
| muscle system process (GO:0003012) | 7.62310399740959e-11 |
| DNA binding (GO:0003677) | 7.6392629832665e-11 |
| protein complex assembly (GO:0006461) | 8.19517266249151e-11 |
| positive regulation of metabolic process (GO:0009893) | 8.19517266249151e-11 |
| metal ion transmembrane transporter activity (GO:0046873) | 1.1534630436618e-10 |
| endosome (GO:0005768) | 1.74436234747273e-10 |
| ion transport (GO:0006811) | 2.89705102944481e-10 |
| calcium ion binding (GO:0005509) | 3.743291721516e-10 |
| positive regulation of transcription (GO:0045941) | 5.83863826408861e-10 |
| endoplasmic reticulum part (GO:0044432) | 7.12909852448103e-10 |
| cation channel activity (GO:0005261) | 7.85178373417263e-10 |
| organelle organization and biogenesis (GO:0006996) | 9.28041817001526e-10 |
| synapse part (GO:0044456) | 9.75141073045902e-10 |
| positive regulation of nucleobase, nucleoside, nucleotide and nucleic acid metabolic process (GO:0045935) | 1.03379861459767e-09 |
| molecular adaptor activity (GO:0060090) | 1.26476189713721e-09 |
| anion binding (GO:0043168) | 1.26476189713721e-09 |
| chloride ion binding (GO:0031404) | 1.26476189713721e-09 |
| enzyme binding (GO:0019899) | 1.40745556729275e-09 |
| sensory perception of mechanical stimulus (GO:0050954) | 1.64490036250442e-09 |
| sensory perception of sound (GO:0007605) | 1.64490036250442e-09 |
| metal ion transport (GO:0030001) | 1.86060136546458e-09 |
| transmembrane receptor protein tyrosine kinase activity (GO:0004714) | 1.9939885503113e-09 |
| positive regulation of transcription, DNA-dependent (GO:0045893) | 2.12414613330591e-09 |
| transcription activator activity (GO:0016563) | 2.88709617547636e-09 |
| leading edge (GO:0031252) | 3.7260625421919e-09 |
| blood circulation (GO:0008015) | 4.35797712146198e-09 |
| circulatory system process (GO:0003013) | 4.35797712146198e-09 |
| angiogenesis (GO:0001525) | 4.42797957914079e-09 |
| establishment of cellular localization (GO:0051649) | 5.04292719583503e-09 |
| regulation of cellular component organization and biogenesis (GO:0051128) | 5.07830282297121e-09 |
| tight junction (GO:0005923) | 5.5643735818995e-09 |
| positive regulation of developmental process (GO:0051094) | 6.69596399259395e-09 |
| morphogenesis of an epithelium (GO:0002009) | 7.06424896051666e-09 |
| skeletal muscle fiber development (GO:0048741) | 8.61533183927877e-09 |
| muscle fiber development (GO:0048747) | 8.61533183927877e-09 |
| phosphoinositide binding (GO:0035091) | 9.54009196186849e-09 |
| dendrite (GO:0030425) | 9.64560981511016e-09 |
| cell-cell adhesion (GO:0016337) | 1.14750554705063e-08 |
| contractile fiber (GO:0043292) | 1.20616406279207e-08 |
| primary metabolic process (GO:0044238) | 1.27667545587328e-08 |
| inorganic anion transport (GO:0015698) | 1.36465830055464e-08 |
| negative regulation of cell proliferation (GO:0008285) | 1.41599804955997e-08 |
| positive regulation of cellular metabolic process (GO:0031325) | 1.76588199774154e-08 |
| nuclear envelope-endoplasmic reticulum network (GO:0042175) | 1.95303039060303e-08 |
| cellular localization (GO:0051641) | 2.03887721174225e-08 |
| receptor binding (GO:0005102) | 2.11579419948344e-08 |
| passive transmembrane transporter activity (GO:0022803) | 2.11882293477336e-08 |
| channel activity (GO:0015267) | 2.11882293477336e-08 |
| contractile fiber part (GO:0044449) | 2.11882293477336e-08 |
| substrate-specific transporter activity (GO:0022892) | 2.19634611086197e-08 |
| embryonic morphogenesis (GO:0048598) | 2.7244205499905e-08 |
| collagen (GO:0005581) | 2.90569242920519e-08 |
| magnesium ion binding (GO:0000287) | 3.07786538969034e-08 |
| regulation of signal transduction (GO:0009966) | 4.35916192826542e-08 |
| substrate specific channel activity (GO:0022838) | 4.52308661099964e-08 |
| endoplasmic reticulum membrane (GO:0005789) | 4.52308661099964e-08 |
| ion channel activity (GO:0005216) | 4.71496148655617e-08 |
| protein localization (GO:0008104) | 5.57403231135102e-08 |
| ubiquitin cycle (GO:0006512) | 5.57403231135102e-08 |
| negative regulation of progression through cell cycle (GO:0045786) | 5.70285045235486e-08 |
| extracellular structure organization and biogenesis (GO:0043062) | 6.85330645664682e-08 |
| macromolecule localization (GO:0033036) | 9.0258814487873e-08 |
| cell death (GO:0008219) | 1.12908455379541e-07 |
| death (GO:0016265) | 1.12908455379541e-07 |
| phospholipid binding (GO:0005543) | 1.54433724104007e-07 |
| protein dimerization activity (GO:0046983) | 1.8040484241562e-07 |
| extracellular matrix structural constituent (GO:0005201) | 1.99527784285128e-07 |
| G-protein signaling, coupled to cyclic nucleotide second messenger (GO:0007187) | 2.14168732224141e-07 |
| regulation of MAP kinase activity (GO:0043405) | 2.33293783043032e-07 |
| endocytosis (GO:0006897) | 2.38294200217281e-07 |
| membrane invagination (GO:0010324) | 2.38294200217281e-07 |
| protein transport (GO:0015031) | 2.68090965966611e-07 |
| integrin binding (GO:0005178) | 3.07974361717054e-07 |
| ossification (GO:0001503) | 3.14273257325608e-07 |
| biomineral formation (GO:0031214) | 3.14273257325608e-07 |
| establishment of protein localization (GO:0045184) | 3.22561329456011e-07 |
| RNA polymerase II transcription factor activity (GO:0003702) | 3.55477835984113e-07 |
| protein homodimerization activity (GO:0042803) | 3.70933101082329e-07 |
| protein complex binding (GO:0032403) | 4.522005454568e-07 |
| structural constituent of muscle (GO:0008307) | 4.62526895970581e-07 |
| cytoskeletal part (GO:0044430) | 4.62526895970581e-07 |
| GTPase activity (GO:0003924) | 5.26095564048766e-07 |
| transcription coactivator activity (GO:0003713) | 5.27358302214483e-07 |
| secretion by cell (GO:0032940) | 5.50831661229201e-07 |
| response to stress (GO:0006950) | 5.56838031555057e-07 |
| coated pit (GO:0005905) | 6.89490412260621e-07 |
| membrane organization and biogenesis (GO:0016044) | 7.6758580673361e-07 |
| regulation of transferase activity (GO:0051338) | 8.2477725585976e-07 |
| regulation of programmed cell death (GO:0043067) | 8.64897587977304e-07 |
| cyclic-nucleotide-mediated signaling (GO:0019935) | 8.65086796595542e-07 |
| extracellular space (GO:0005615) | 1.11622950698587e-06 |
| monovalent inorganic cation transport (GO:0015672) | 1.11622950698587e-06 |
| phosphate transport (GO:0006817) | 1.22393005345791e-06 |
| apical part of cell (GO:0045177) | 1.22848268692166e-06 |
| cellular metabolic process (GO:0044237) | 1.28762448215513e-06 |
| substrate-specific transmembrane transporter activity (GO:0022891) | 1.41883119228654e-06 |
| cation transmembrane transporter activity (GO:0008324) | 1.44225236346849e-06 |
| regulation of cell differentiation (GO:0045595) | 1.53841328975317e-06 |
| lipid metabolic process (GO:0006629) | 1.74896234028661e-06 |
| gliogenesis (GO:0042063) | 1.80063928203758e-06 |
| cation transport (GO:0006812) | 2.06173212660326e-06 |
| transmembrane transporter activity (GO:0022857) | 2.1757836253662e-06 |
| diacylglycerol binding (GO:0019992) | 2.25643549619339e-06 |
| heparin binding (GO:0008201) | 2.28981280226831e-06 |
| chloride channel activity (GO:0005254) | 2.37489950570125e-06 |
| anion transport (GO:0006820) | 2.37489950570125e-06 |
| regulation of apoptosis (GO:0042981) | 2.37489950570125e-06 |
| programmed cell death (GO:0012501) | 2.71193088373412e-06 |
| secretory pathway (GO:0045045) | 2.91459774720241e-06 |
| coated vesicle (GO:0030135) | 3.0189008097878e-06 |
| cell fate commitment (GO:0045165) | 3.04766727281901e-06 |
| protein domain specific binding (GO:0019904) | 3.09192420118154e-06 |
| myofibril (GO:0030016) | 3.86454863279755e-06 |
| clathrin-coated vesicle (GO:0030136) | 4.10713209492346e-06 |
| bone remodeling (GO:0046849) | 4.21413702207474e-06 |
| macromolecule metabolic process (GO:0043170) | 5.41931049276537e-06 |
| microtubule (GO:0005874) | 5.52671336238534e-06 |
| SH3/SH2 adaptor activity (GO:0005070) | 5.76234944413703e-06 |
| glycosaminoglycan binding (GO:0005539) | 6.06489747044122e-06 |
| ion transmembrane transporter activity (GO:0015075) | 6.20330423566095e-06 |
| tube development (GO:0035295) | 6.85241008005304e-06 |
| regulation of a molecular function (GO:0065009) | 7.83794577898495e-06 |
| cell soma (GO:0043025) | 8.12584308973367e-06 |
| determination of symmetry (GO:0009799) | 8.19200759401186e-06 |
| determination of bilateral symmetry (GO:0009855) | 8.19200759401186e-06 |
| determination of left/right symmetry (GO:0007368) | 8.19200759401186e-06 |
| endosomal part (GO:0044440) | 8.62677566025739e-06 |
| endosome membrane (GO:0010008) | 8.62677566025739e-06 |
| organelle lumen (GO:0043233) | 8.63644616767885e-06 |
| membrane-enclosed lumen (GO:0031974) | 8.63644616767885e-06 |
| two-component signal transduction system (phosphorelay) (GO:0000160) | 8.72931780774625e-06 |
| tissue remodeling (GO:0048771) | 8.72931780774625e-06 |
| regulation of cell cycle (GO:0051726) | 1.01999943094423e-05 |
| apoptosis (GO:0006915) | 1.05788110567319e-05 |
| intracellular transport (GO:0046907) | 1.06459496138885e-05 |
| transport vesicle (GO:0030133) | 1.13392696246366e-05 |
| reproductive developmental process (GO:0003006) | 1.15457860084292e-05 |
| chromatin modification (GO:0016568) | 1.17030825784291e-05 |
| regulation of kinase activity (GO:0043549) | 1.22040184297021e-05 |
| positive regulation of transferase activity (GO:0051347) | 1.28286488008294e-05 |
| regulation of progression through cell cycle (GO:0000074) | 1.28354937682098e-05 |
| reproductive process (GO:0022414) | 1.31795455211556e-05 |
| nucleobase, nucleoside, nucleotide and nucleic acid metabolic process (GO:0006139) | 1.41792323651886e-05 |
| extrinsic to membrane (GO:0019898) | 1.45394739664276e-05 |
| cell surface (GO:0009986) | 1.56463507265528e-05 |
| regulation of protein kinase activity (GO:0045859) | 1.79171630760065e-05 |
| postsynaptic membrane (GO:0045211) | 1.91882350428775e-05 |
| neurological system process (GO:0050877) | 2.11356735707818e-05 |
| sarcomere (GO:0030017) | 2.12941157471806e-05 |
| protein complex (GO:0043234) | 2.36174871850048e-05 |
| sodium ion binding (GO:0031402) | 2.44928064072217e-05 |
| cytoplasm organization and biogenesis (GO:0007028) | 2.46840799900165e-05 |
| sarcolemma (GO:0042383) | 2.48696299353657e-05 |
| cellular lipid metabolic process (GO:0044255) | 2.48696299353657e-05 |
| polysaccharide binding (GO:0030247) | 2.57952692368644e-05 |
| positive regulation of catalytic activity (GO:0043085) | 2.91320140726529e-05 |
| amine transport (GO:0015837) | 2.95858940694917e-05 |
| G-protein signaling, coupled to cAMP nucleotide second messenger (GO:0007188) | 2.95858940694917e-05 |
| regulation of transport (GO:0051049) | 3.01919976433144e-05 |
| mesoderm development (GO:0007498) | 3.15775916112313e-05 |
| regulation of locomotion (GO:0040012) | 3.28428701499677e-05 |
| lamellipodium (GO:0030027) | 3.365558508069e-05 |
| Wnt receptor signaling pathway (GO:0016055) | 3.43466974981286e-05 |
| Notch signaling pathway (GO:0007219) | 3.74445434683177e-05 |
| in utero embryonic development (GO:0001701) | 3.74445434683177e-05 |
| positive regulation of programmed cell death (GO:0043068) | 3.74445434683177e-05 |
| steroid binding (GO:0005496) | 3.89846908507292e-05 |
| locomotion (GO:0040011) | 4.49834305383262e-05 |
| actin polymerization and/or depolymerization (GO:0008154) | 4.50038781749914e-05 |
| mesoderm morphogenesis (GO:0048332) | 4.6341486872364e-05 |
| neuroblast proliferation (GO:0007405) | 4.6341486872364e-05 |
| neurotransmitter secretion (GO:0007269) | 4.63565831181505e-05 |
| nucleoplasm (GO:0005654) | 4.86628334259841e-05 |
| manganese ion binding (GO:0030145) | 4.98793734517391e-05 |
| protein processing (GO:0016485) | 5.14535444606702e-05 |
| muscle cell differentiation (GO:0042692) | 5.67778911538681e-05 |
| forebrain development (GO:0030900) | 5.67778911538681e-05 |
| receptor signaling protein activity (GO:0005057) | 5.81843611295152e-05 |
| nucleoplasm part (GO:0044451) | 5.8378825573658e-05 |
| small GTPase mediated signal transduction (GO:0007264) | 5.96224838293584e-05 |
| protein C-terminus binding (GO:0008022) | 6.00554393072851e-05 |
| behavior (GO:0007610) | 6.15302702737633e-05 |
| pattern binding (GO:0001871) | 6.1900418180045e-05 |
| apical plasma membrane (GO:0016324) | 6.22635980910361e-05 |
| opioid peptide activity (GO:0001515) | 6.22635980910361e-05 |
| negative regulation of catalytic activity (GO:0043086) | 6.59048462399379e-05 |
| cAMP-mediated signaling (GO:0019933) | 6.59048462399379e-05 |
| neuron migration (GO:0001764) | 6.64189338476458e-05 |
| cell projection part (GO:0044463) | 7.43366039184886e-05 |
| intercellular junction assembly (GO:0007043) | 7.43446866980732e-05 |
| positive regulation of apoptosis (GO:0043065) | 7.77591128720692e-05 |
| regulation of catalytic activity (GO:0050790) | 7.91126243894162e-05 |
| intercellular junction assembly and maintenance (GO:0045216) | 8.07007643451103e-05 |
| excretion (GO:0007588) | 8.43969057380201e-05 |
| amino acid transmembrane transporter activity (GO:0015171) | 8.67627650854445e-05 |
| response to chemical stimulus (GO:0042221) | 9.03511636114441e-05 |
| microtubule associated complex (GO:0005875) | 9.20654238810244e-05 |
| insulin receptor signaling pathway (GO:0008286) | 9.48156617096783e-05 |
| adherens junction (GO:0005912) | 0.000105025941901462 |
| fibrillar collagen (GO:0005583) | 0.000108404128325927 |
| cell surface receptor linked signal transduction (GO:0007166) | 0.000113794837504174 |
| regulation of neurogenesis (GO:0050767) | 0.000127295048856502 |
| anterior/posterior pattern formation (GO:0009952) | 0.000134868133414213 |
| protein amino acid phosphorylation (GO:0006468) | 0.000157947702773052 |
| positive regulation of transcription from RNA polymerase II promoter (GO:0045944) | 0.00015864252966712 |
| establishment and/or maintenance of cell polarity (GO:0007163) | 0.000194878102768305 |
| amine transmembrane transporter activity (GO:0005275) | 0.000194878102768305 |
| glial cell differentiation (GO:0010001) | 0.000194878102768305 |
| structural constituent of cytoskeleton (GO:0005200) | 0.000212198871804346 |
| positive regulation of MAP kinase activity (GO:0043406) | 0.000225271140902224 |
| PDZ domain binding (GO:0030165) | 0.000225271140902224 |
| two-component sensor activity (GO:0000155) | 0.000225271140902224 |
| presynaptic membrane (GO:0042734) | 0.000231685972014399 |
| urogenital system development (GO:0001655) | 0.000231685972014399 |
| positive regulation of cell proliferation (GO:0008284) | 0.000231988535732634 |
| nuclear part (GO:0044428) | 0.000232735635634105 |
| vesicle membrane (GO:0012506) | 0.000251763440046569 |
| anion channel activity (GO:0005253) | 0.000304306708369985 |
| Rho protein signal transduction (GO:0007266) | 0.000305134537769482 |
| actin filament organization (GO:0007015) | 0.000307913561014726 |
| cytoplasmic vesicle part (GO:0044433) | 0.000308195764128291 |
| recycling endosome membrane (GO:0055038) | 0.000313823612110895 |
| sheet-forming collagen (GO:0030935) | 0.000313823612110895 |
| mitochondrion (GO:0005739) | 0.000328893827389097 |
| cell cycle (GO:0007049) | 0.000332216197225679 |
| phosphorus metabolic process (GO:0006793) | 0.000339937158595367 |
| phosphate metabolic process (GO:0006796) | 0.000339937158595367 |
| synaptic vesicle (GO:0008021) | 0.000353251284635196 |
| sterol metabolic process (GO:0016125) | 0.00035992949013728 |
| positive regulation of kinase activity (GO:0033674) | 0.000371219653750397 |
| sex differentiation (GO:0007548) | 0.000397477479744401 |
| neutral amino acid transmembrane transporter activity (GO:0015175) | 0.000425872689751145 |
| embryonic skeletal development (GO:0048706) | 0.000443000117452019 |
| regulation of cell motility (GO:0051270) | 0.000524433676290046 |
| L-amino acid transmembrane transporter activity (GO:0015179) | 0.000531153130965093 |
| neurotransmitter metabolic process (GO:0042133) | 0.000531153130965093 |
| endocytic vesicle (GO:0030139) | 0.000535715452940796 |
| RNA polymerase II transcription factor activity, enhancer binding (GO:0003705) | 0.000559632287929898 |
| myoblast differentiation (GO:0045445) | 0.000559632287929898 |
| nuclear lumen (GO:0031981) | 0.000579513006025522 |
| protein-tyrosine kinase activity (GO:0004713) | 0.000582861522293819 |
| behavioral defense response (GO:0002209) | 0.00061949056400623 |
| behavioral fear response (GO:0001662) | 0.00061949056400623 |
| G-protein activated inward rectifier potassium channel activity (GO:0015467) | 0.00061949056400623 |
| regulation of cytoskeleton organization and biogenesis (GO:0051493) | 0.000659316782880347 |
| regulation of organelle organization and biogenesis (GO:0033043) | 0.000659316782880347 |
| negative regulation of signal transduction (GO:0009968) | 0.000683063680127117 |
| transcription factor complex (GO:0005667) | 0.000685586748914187 |
| receptor signaling protein serine/threonine kinase activity (GO:0004702) | 0.000752503987288402 |
| cell cortex (GO:0005938) | 0.000758781855099471 |
| positive regulation of protein kinase activity (GO:0045860) | 0.000758781855099471 |
| dorsal/ventral pattern formation (GO:0009953) | 0.000778119943235255 |
| embryonic pattern specification (GO:0009880) | 0.000778119943235255 |
| zinc ion transport (GO:0006829) | 0.000781916112804468 |
| tube morphogenesis (GO:0035239) | 0.000796512581554997 |
| regulation of multicellular organismal process (GO:0051239) | 0.000816508901785712 |
| cytoplasmic vesicle membrane (GO:0030659) | 0.000821547050598465 |
| induction of apoptosis (GO:0006917) | 0.000867279825764508 |
| protein kinase activity (GO:0004672) | 0.000909469599863666 |
| response to external stimulus (GO:0009605) | 0.000910652146059662 |
| fear response (GO:0042596) | 0.000935210135680259 |
| mRNA binding (GO:0003729) | 0.000944470077216791 |
| induction of programmed cell death (GO:0012502) | 0.000973322745489624 |
| cell cycle process (GO:0022402) | 0.00097777038617332 |
| protein serine/threonine phosphatase activity (GO:0004722) | 0.000979955186742424 |
| nerve-nerve synaptic transmission (GO:0007270) | 0.00104757030558442 |
| extracellular matrix organization and biogenesis (GO:0030198) | 0.00105685595108623 |
| negative regulation of programmed cell death (GO:0043069) | 0.00105685595108623 |
| response to protein stimulus (GO:0051789) | 0.00108729281269028 |
| response to unfolded protein (GO:0006986) | 0.00108729281269028 |
| peroxisome (GO:0005777) | 0.00121975550793664 |
| microbody (GO:0042579) | 0.00121975550793664 |
| transition metal ion binding (GO:0046914) | 0.00124753435628576 |
| regulated secretory pathway (GO:0045055) | 0.00127326673818507 |
| mesoderm formation (GO:0001707) | 0.0012899091480681 |
| neutral amino acid transport (GO:0015804) | 0.0012899091480681 |
| positive regulation of cell differentiation (GO:0045597) | 0.00131500988307323 |
| regulation of cellular component size (GO:0032535) | 0.00131500988307323 |
| regulation of cell migration (GO:0030334) | 0.00143200624164928 |
| positive regulation of signal transduction (GO:0009967) | 0.00143549337836825 |
| protein complex scaffold (GO:0032947) | 0.00155606958812904 |
| actin filament (GO:0005884) | 0.00155606958812904 |
| regulation of JNK activity (GO:0043506) | 0.00155606958812904 |
| gastrulation (GO:0007369) | 0.00155606958812904 |
| ectoderm development (GO:0007398) | 0.00157337420662514 |
| protein serine/threonine kinase activity (GO:0004674) | 0.00158070434205619 |
| kidney development (GO:0001822) | 0.00159269975504014 |
| cellular component assembly (GO:0022607) | 0.00159640553755552 |
| response to hypoxia (GO:0001666) | 0.00162055414223109 |
| regulation of cell morphogenesis (GO:0022604) | 0.0016393780905453 |
| regulation of anatomical structure morphogenesis (GO:0022603) | 0.0016393780905453 |
| regulation of cell shape (GO:0008360) | 0.0016393780905453 |
| anti-apoptosis (GO:0006916) | 0.00171278010591865 |
| negative regulation of apoptosis (GO:0043066) | 0.00182976812667226 |
| steroid hormone receptor activity (GO:0003707) | 0.00186079320414366 |
| fibroblast growth factor receptor signaling pathway (GO:0008543) | 0.00203178492923263 |
| limb development (GO:0060173) | 0.00203566735807173 |
| appendage development (GO:0048736) | 0.00203566735807173 |
| appendage morphogenesis (GO:0035107) | 0.00203566735807173 |
| limb morphogenesis (GO:0035108) | 0.00203566735807173 |
| regulation of axonogenesis (GO:0050770) | 0.0021145011617987 |
| inward rectifier potassium channel activity (GO:0005242) | 0.0021145011617987 |
| myosin II complex (GO:0016460) | 0.0021145011617987 |
| protein import into nucleus (GO:0006606) | 0.00214592731900678 |
| phosphoric ester hydrolase activity (GO:0042578) | 0.00215516403710487 |
| SNARE binding (GO:0000149) | 0.0022088722147897 |
| axon guidance (GO:0007411) | 0.00223988285267577 |
| intracellular protein transport (GO:0006886) | 0.00230916607105859 |
| multicellular organismal response to stress (GO:0033555) | 0.00235697480804648 |
| sexual reproduction (GO:0019953) | 0.00245658583458419 |
| regulation of pseudopodium formation (GO:0031272) | 0.00245658583458419 |
| advanced glycation end-product receptor activity (GO:0050785) | 0.00245658583458419 |
| pseudopodium organization and biogenesis (GO:0031268) | 0.00245658583458419 |
| embryonic forelimb morphogenesis (GO:0035115) | 0.00245658583458419 |
| collagen type IV (GO:0005587) | 0.00245658583458419 |
| pseudopodium formation (GO:0031269) | 0.00245658583458419 |
| vinculin binding (GO:0017166) | 0.00245658583458419 |
| positive regulation of pseudopodium formation (GO:0031274) | 0.00245658583458419 |
| forelimb morphogenesis (GO:0035136) | 0.00245658583458419 |
| regulation of phosphorus metabolic process (GO:0051174) | 0.00250493306387088 |
| regulation of phosphate metabolic process (GO:0019220) | 0.00250493306387088 |
| activation of MAPK activity (GO:0000187) | 0.00265595350974426 |
| adult behavior (GO:0030534) | 0.00281694351021316 |
| formation of primary germ layer (GO:0001704) | 0.00301959244726295 |
| learning (GO:0007612) | 0.00301959244726295 |
| nuclear import (GO:0051170) | 0.00303408410668408 |
| fatty acid metabolic process (GO:0006631) | 0.00306343774321096 |
| embryonic limb morphogenesis (GO:0030326) | 0.00312880829552303 |
| embryonic appendage morphogenesis (GO:0035113) | 0.00312880829552303 |
| amino acid transport (GO:0006865) | 0.00313912045344999 |
| negative regulation of developmental process (GO:0051093) | 0.00322122296551053 |
| negative regulation of cellular component organization and biogenesis (GO:0051129) | 0.00353227566696706 |
| kinase binding (GO:0019900) | 0.00360913282322467 |
| centrosome (GO:0005813) | 0.00360913282322467 |
| soluble fraction (GO:0005625) | 0.00363736227129253 |
| protein histidine kinase activity (GO:0004673) | 0.00372939245404933 |
| ephrin receptor activity (GO:0005003) | 0.00372939245404933 |
| regulation of phosphorylation (GO:0042325) | 0.00372939245404933 |
| regulation of actin filament length (GO:0030832) | 0.00380051336901942 |
| delayed rectifier potassium channel activity (GO:0005251) | 0.00380248213491805 |
| positive regulation of myeloid cell differentiation (GO:0045639) | 0.00380248213491805 |
| cell-cell adherens junction (GO:0005913) | 0.00380248213491805 |
| negative regulation of progression through mitotic cell cycle (GO:0045930) | 0.00380248213491805 |
| protein catabolic process (GO:0030163) | 0.00384230318547993 |
| protein metabolic process (GO:0019538) | 0.00384230318547993 |
| cholesterol metabolic process (GO:0008203) | 0.00389612646182798 |
| kinase regulator activity (GO:0019207) | 0.00389612646182798 |
| hormone secretion (GO:0046879) | 0.00394162531840842 |
| axon (GO:0030424) | 0.00394162531840842 |
| neuromuscular synaptic transmission (GO:0007274) | 0.00402991700816336 |
| embryonic skeletal morphogenesis (GO:0048704) | 0.00402991700816336 |
| developmental maturation (GO:0021700) | 0.00413851771994634 |
| hindbrain development (GO:0030902) | 0.00413851771994634 |
| negative regulation of cell motility (GO:0051271) | 0.00413851771994634 |
| positive regulation of JNK activity (GO:0043507) | 0.00413851771994634 |
| histone deacetylase complex (GO:0000118) | 0.00413851771994634 |
| kinase activator activity (GO:0019209) | 0.00428126661306274 |
| receptor signaling complex scaffold activity (GO:0030159) | 0.00428126661306274 |
| microvillus (GO:0005902) | 0.00428126661306274 |
| polypeptide N-acetylgalactosaminyltransferase activity (GO:0004653) | 0.00428126661306274 |
| growth factor activity (GO:0008083) | 0.00428126661306274 |
| GABA receptor activity (GO:0016917) | 0.00449656621030522 |
| intercalated disc (GO:0014704) | 0.00449656621030522 |
| regulation of actin cytoskeleton organization and biogenesis (GO:0032956) | 0.00449656621030522 |
| integrin-mediated signaling pathway (GO:0007229) | 0.0045450978498686 |
| cell fate determination (GO:0001709) | 0.00474426655305444 |
| microtubule organizing center (GO:0005815) | 0.00484466569429473 |
| lipid biosynthetic process (GO:0008610) | 0.00493123147728235 |
| gamete generation (GO:0007276) | 0.00532854279440867 |
| negative regulation of transferase activity (GO:0051348) | 0.00540748948858273 |
| regulation of secretion (GO:0051046) | 0.00540748948858273 |
| ubiquitin-protein ligase activity (GO:0004842) | 0.00542140459096504 |
| carbonyl reductase (NADPH) activity (GO:0004090) | 0.00542140459096504 |
| glutamate catabolic process (GO:0006538) | 0.00542140459096504 |
| endochondral ossification (GO:0001958) | 0.00542140459096504 |
| subpallium development (GO:0021544) | 0.00542140459096504 |
| elastic fiber assembly (GO:0048251) | 0.00542140459096504 |
| MAP-kinase scaffold activity (GO:0005078) | 0.00542140459096504 |
| alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity (GO:0004971) | 0.00542140459096504 |
| mitochondrial crista (GO:0030061) | 0.00542140459096504 |
| choline transmembrane transporter activity (GO:0015220) | 0.00542140459096504 |
| choline transport (GO:0015871) | 0.00542140459096504 |
| establishment of apical/basal cell polarity (GO:0035089) | 0.00542140459096504 |
| negative regulation of locomotion (GO:0040013) | 0.00544522754176521 |
| negative regulation of MAP kinase activity (GO:0043407) | 0.00544522754176521 |
| metanephros development (GO:0001656) | 0.00544522754176521 |
| cAMP binding (GO:0030552) | 0.0056958018029188 |
| amino acid derivative catabolic process (GO:0042219) | 0.0056958018029188 |
| regulation of heart contraction (GO:0008016) | 0.00577430685754394 |
| negative regulation of cell migration (GO:0030336) | 0.00594272980615975 |
| actin filament bundle formation (GO:0051017) | 0.00594272980615975 |
| syntaxin binding (GO:0019905) | 0.00594272980615975 |
| fibroblast growth factor receptor activity (GO:0005007) | 0.00596738704105775 |
| carnitine O-acyltransferase activity (GO:0016406) | 0.00596738704105775 |
| positive regulation of cell projection organization and biogenesis (GO:0031346) | 0.00596738704105775 |
| regulation of cell projection organization and biogenesis (GO:0031344) | 0.00596738704105775 |
| response to abiotic stimulus (GO:0009628) | 0.00596738704105775 |
| cartilage development (GO:0051216) | 0.00596738704105775 |
| steroid metabolic process (GO:0008202) | 0.00596738704105775 |
| biopolymer catabolic process (GO:0043285) | 0.00602910382361879 |
| catabolic process (GO:0009056) | 0.0063954314131104 |
| phosphorylation (GO:0016310) | 0.00647962976605282 |
| small protein conjugating enzyme activity (GO:0008639) | 0.00669538362304101 |
| tubulin binding (GO:0015631) | 0.00677055868442976 |
| recycling endosome (GO:0055037) | 0.00679485215803597 |
| beta-amyloid binding (GO:0001540) | 0.00679485215803597 |
| neuromuscular junction development (GO:0007528) | 0.00679485215803597 |
| phosphoric monoester hydrolase activity (GO:0016791) | 0.00697863130718414 |
| cyclic nucleotide binding (GO:0030551) | 0.00710055141591981 |
| muscle myosin complex (GO:0005859) | 0.00710055141591981 |
| cortical cytoskeleton (GO:0030863) | 0.00710055141591981 |
| second-messenger-mediated signaling (GO:0019932) | 0.00714985349174169 |
| growth factor binding (GO:0019838) | 0.00741117768645588 |
| steroid biosynthetic process (GO:0006694) | 0.00741117768645588 |
| transforming growth factor beta receptor signaling pathway (GO:0007179) | 0.00749682239602005 |
| cell projection biogenesis (GO:0030031) | 0.00749682239602005 |
| negative regulation of kinase activity (GO:0033673) | 0.00779224018615159 |
| negative regulation of protein kinase activity (GO:0006469) | 0.00779224018615159 |
| regulation of protein metabolic process (GO:0051246) | 0.00803849833574705 |
| negative regulation of growth (GO:0045926) | 0.0081130505336936 |
| carboxylic acid transmembrane transporter activity (GO:0046943) | 0.0081130505336936 |
| response to oxidative stress (GO:0006979) | 0.00821625501524212 |
| insulin secretion (GO:0030073) | 0.00828424385155655 |
| regulation of actin polymerization and/or depolymerization (GO:0008064) | 0.00828424385155655 |
| learning and/or memory (GO:0007611) | 0.00828424385155655 |
| protein amino acid autophosphorylation (GO:0046777) | 0.00828424385155655 |
| macromolecular complex assembly (GO:0065003) | 0.0089200759818389 |
| cell-substrate adherens junction (GO:0005924) | 0.00901762008133937 |
| vesicular fraction (GO:0042598) | 0.00918255255162911 |
| gamma-aminobutyric acid signaling pathway (GO:0007214) | 0.00918255255162911 |
| eye morphogenesis (GO:0048592) | 0.00918255255162911 |
| ubiquitin ligase complex (GO:0000151) | 0.00921978464860382 |
| phosphotransferase activity, nitrogenous group as acceptor (GO:0016775) | 0.00936504958030088 |
| carboxylic acid transport (GO:0046942) | 0.00940777955824417 |
| transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178) | 0.00965558302261357 |
| cell maturation (GO:0048469) | 0.00995649494760337 |
| microsome (GO:0005792) | 0.0104649965625963 |
| AMP binding (GO:0016208) | 0.0107857696852954 |
| phospholipid dephosphorylation (GO:0046839) | 0.0107857696852954 |
| calmodulin-dependent protein kinase activity (GO:0004683) | 0.0107857696852954 |
| activation of JNK activity (GO:0007257) | 0.0107857696852954 |
| clathrin binding (GO:0030276) | 0.0107857696852954 |
| guanylate kinase activity (GO:0004385) | 0.0107857696852954 |
| estrogen receptor signaling pathway (GO:0030520) | 0.0107857696852954 |
| oligodendrocyte differentiation (GO:0048709) | 0.0107857696852954 |
| GABA-A receptor activity (GO:0004890) | 0.0107857696852954 |
| synapse organization and biogenesis (GO:0050808) | 0.0107857696852954 |
| regulation of muscle contraction (GO:0006937) | 0.0107857696852954 |
| specific RNA polymerase II transcription factor activity (GO:0003704) | 0.0107857696852954 |
| organic acid transmembrane transporter activity (GO:0005342) | 0.0107857696852954 |
| organic acid transport (GO:0015849) | 0.0107857696852954 |
| positive regulation of I-kappaB kinase/NF-kappaB cascade (GO:0043123) | 0.0107857696852954 |
| non-membrane-bound organelle (GO:0043228) | 0.011479992344915 |
| intracellular non-membrane-bound organelle (GO:0043232) | 0.011479992344915 |
| sterol biosynthetic process (GO:0016126) | 0.011479992344915 |
| epidermal growth factor receptor signaling pathway (GO:0007173) | 0.011479992344915 |
| segmentation (GO:0035282) | 0.011486447088299 |
| vesicle organization and biogenesis (GO:0016050) | 0.011486447088299 |
| myosin filament (GO:0032982) | 0.011486447088299 |
| positive regulation of neurogenesis (GO:0050769) | 0.011486447088299 |
| SMAD binding (GO:0046332) | 0.011486447088299 |
| striated muscle thick filament (GO:0005863) | 0.011486447088299 |
| basal part of cell (GO:0045178) | 0.011486447088299 |
| basal plasma membrane (GO:0009925) | 0.011486447088299 |
| protein depolymerization (GO:0051261) | 0.011486447088299 |
| protein autoprocessing (GO:0016540) | 0.011486447088299 |
| striated muscle cell development (GO:0055002) | 0.011486447088299 |
| muscle cell development (GO:0055001) | 0.011486447088299 |
| negative regulation of S phase of mitotic cell cycle (GO:0045749) | 0.011486447088299 |
| negative regulation of cell-matrix adhesion (GO:0001953) | 0.011486447088299 |
| FK506 binding (GO:0005528) | 0.011486447088299 |
| macrolide binding (GO:0005527) | 0.011486447088299 |
| myofibril assembly (GO:0030239) | 0.011486447088299 |
| clathrin-coated endocytic vesicle (GO:0045334) | 0.011486447088299 |
| gene expression (GO:0010467) | 0.0116083672766209 |
| negative regulation of cell growth (GO:0030308) | 0.0117727888967917 |
| chemical homeostasis (GO:0048878) | 0.0121664238455304 |
| small GTPase binding (GO:0031267) | 0.0123644551729128 |
| ion homeostasis (GO:0050801) | 0.0126488711236295 |
| regulation of I-kappaB kinase/NF-kappaB cascade (GO:0043122) | 0.0126736221983866 |
| basal lamina (GO:0005605) | 0.0126736221983866 |
| cell-matrix junction (GO:0030055) | 0.0126736221983866 |
| endosome transport (GO:0016197) | 0.0126736221983866 |
| neurotransmitter transport (GO:0006836) | 0.0131518052817349 |
| phosphotransferase activity, alcohol group as acceptor (GO:0016773) | 0.0132700590262117 |
| heart contraction (GO:0060047) | 0.0134663903452028 |
| heart process (GO:0003015) | 0.0134663903452028 |
| negative regulation of cell size (GO:0045792) | 0.0136509804155781 |
| morphogenesis of embryonic epithelium (GO:0016331) | 0.0136509804155781 |
| clathrin vesicle coat (GO:0030125) | 0.0136509804155781 |
| calcium-independent cell-cell adhesion (GO:0016338) | 0.0136509804155781 |
| dystrophin-associated glycoprotein complex (GO:0016010) | 0.0136509804155781 |
| Ras protein signal transduction (GO:0007265) | 0.0137171662934924 |
| phosphoprotein phosphatase activity (GO:0004721) | 0.0138734428789209 |
| cell cycle arrest (GO:0007050) | 0.0139000885329145 |
| response to wounding (GO:0009611) | 0.0139218083568732 |
| glycoprotein biosynthetic process (GO:0009101) | 0.0139486775876326 |
| perinuclear region of cytoplasm (GO:0048471) | 0.0140652801246413 |
| oxidoreductase activity, acting on the CH-NH2 group of donors (GO:0016638) | 0.0141043854829321 |
| sensory organ development (GO:0007423) | 0.0142565973904458 |
| zinc ion binding (GO:0008270) | 0.0143217113567697 |
| glycoprotein metabolic process (GO:0009100) | 0.014557396735543 |
| regulation of adenylate cyclase activity (GO:0045761) | 0.0150155023778399 |
| cilium (GO:0005929) | 0.0150155023778399 |
| telomere maintenance via telomerase (GO:0007004) | 0.0155995767018346 |
| regulation of blood pressure (GO:0008217) | 0.0157686613691173 |
| regulation of neurotransmitter secretion (GO:0046928) | 0.0157754842809785 |
| protein kinase activator activity (GO:0030295) | 0.0157754842809785 |
| regulation of anti-apoptosis (GO:0045767) | 0.0157754842809785 |
| anion transmembrane transporter activity (GO:0008509) | 0.0158418041974482 |
| receptor complex (GO:0043235) | 0.0163056949277204 |
| chloride transport (GO:0006821) | 0.016382493524312 |
| epithelial cell maturation (GO:0002070) | 0.016382493524312 |
| poly(U) binding (GO:0008266) | 0.016382493524312 |
| dihydropyrimidinase activity (GO:0004157) | 0.016382493524312 |
| negative regulation of telomere maintenance (GO:0032205) | 0.016382493524312 |
| receptor tyrosine kinase binding (GO:0030971) | 0.016382493524312 |
| muscle thin filament tropomyosin (GO:0005862) | 0.016382493524312 |
| carnitine metabolic process (GO:0009437) | 0.016382493524312 |
| cognition (GO:0050890) | 0.016382493524312 |
| retinoid X receptor binding (GO:0046965) | 0.016382493524312 |
| follistatin binding (GO:0048184) | 0.016382493524312 |
| negative regulation of cell differentiation (GO:0045596) | 0.0167024006069466 |
| oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor (GO:0016641) | 0.017319016069655 |
| insulin receptor binding (GO:0005158) | 0.017319016069655 |
| clathrin coated vesicle membrane (GO:0030665) | 0.017319016069655 |
| fatty acid oxidation (GO:0019395) | 0.0173211904935313 |
| regulation of lyase activity (GO:0051339) | 0.0175749625076802 |
| regulation of cyclase activity (GO:0031279) | 0.0175749625076802 |
| nuclear hormone receptor binding (GO:0035257) | 0.0179034681853268 |
| early endosome (GO:0005769) | 0.0180304772909136 |
| exocytosis (GO:0006887) | 0.0182500276747398 |
| estrogen receptor binding (GO:0030331) | 0.0193351091127909 |
| axon cargo transport (GO:0008088) | 0.0193351091127909 |
| muscle morphogenesis (GO:0048644) | 0.0193351091127909 |
| protein heterooligomerization (GO:0051291) | 0.0193351091127909 |
| negative regulation of amino acid metabolic process (GO:0045763) | 0.0193351091127909 |
| cardiac muscle morphogensis (GO:0055008) | 0.0193351091127909 |
| protein-lysine 6-oxidase activity (GO:0004720) | 0.0193351091127909 |
| metencephalon development (GO:0022037) | 0.0193351091127909 |
| actin cytoskeleton reorganization (GO:0031532) | 0.0193351091127909 |
| negative regulation of amine metabolic process (GO:0033239) | 0.0193351091127909 |
| cerebellum development (GO:0021549) | 0.0193351091127909 |
| negative regulation of protein amino acid phosphorylation (GO:0001933) | 0.0193351091127909 |
| midbrain development (GO:0030901) | 0.0193351091127909 |
| kainate selective glutamate receptor activity (GO:0015277) | 0.0193351091127909 |
| channel regulator activity (GO:0016247) | 0.0193940528385353 |
| epithelial cell differentiation (GO:0030855) | 0.0193940528385353 |
| protein serine/threonine phosphatase complex (GO:0008287) | 0.0202892783734371 |
| hormone receptor binding (GO:0051427) | 0.0202892783734371 |
| inactivation of MAPK activity (GO:0000188) | 0.0202892783734371 |
| vasculogenesis (GO:0001570) | 0.0202892783734371 |
| transforming growth factor beta receptor activity (GO:0005024) | 0.0202892783734371 |
| transmembrane receptor protein serine/threonine kinase activity (GO:0004675) | 0.0202892783734371 |
| acetylgalactosaminyltransferase activity (GO:0008376) | 0.0210105374716424 |
| Golgi vesicle transport (GO:0048193) | 0.0216239696497025 |
| peripheral nervous system development (GO:0007422) | 0.0216861681274855 |
| biogenic amine metabolic process (GO:0006576) | 0.02197607135094 |
| focal adhesion formation (GO:0048041) | 0.0220748105266349 |
| clathrin coat of coated pit (GO:0030132) | 0.0220748105266349 |
| camera-type eye morphogenesis (GO:0048593) | 0.0220748105266349 |
| cation:amino acid symporter activity (GO:0005416) | 0.0220748105266349 |
| regulation of cell-matrix adhesion (GO:0001952) | 0.0220748105266349 |
| positive regulation of axonogenesis (GO:0050772) | 0.0220748105266349 |
| GTPase binding (GO:0051020) | 0.0222661211007056 |
| protein kinase regulator activity (GO:0019887) | 0.0226795300775194 |
| nucleocytoplasmic transport (GO:0006913) | 0.0229847486308005 |
| phosphatase regulator activity (GO:0019208) | 0.0235143647046872 |
| sensory perception of light stimulus (GO:0050953) | 0.0235595541064794 |
| visual perception (GO:0007601) | 0.0235595541064794 |
| late endosome (GO:0005770) | 0.0236825467960892 |
| steroid hormone receptor signaling pathway (GO:0030518) | 0.0236825467960892 |
| homophilic cell adhesion (GO:0007156) | 0.0245150706024959 |
| amino acid derivative metabolic process (GO:0006575) | 0.024627165054994 |
| kinetochore (GO:0000776) | 0.025423803349214 |
| chromosome, telomeric region (GO:0000781) | 0.025423803349214 |
| metalloendopeptidase activity (GO:0004222) | 0.0259853827309927 |
| symporter activity (GO:0015293) | 0.0260511615214584 |
| monocarboxylic acid metabolic process (GO:0032787) | 0.0261782966233685 |
| peptide secretion (GO:0002790) | 0.0263150248809046 |
| transmembrane receptor protein phosphatase activity (GO:0019198) | 0.0263150248809046 |
| regulation of hormone secretion (GO:0046883) | 0.0263150248809046 |
| transmembrane receptor protein tyrosine phosphatase activity (GO:0005001) | 0.0263150248809046 |
| ureteric bud development (GO:0001657) | 0.0263150248809046 |
| peptide hormone secretion (GO:0030072) | 0.0263150248809046 |
| pigment granule (GO:0048770) | 0.0269675927420458 |
| protein kinase binding (GO:0019901) | 0.0269675927420458 |
| melanosome (GO:0042470) | 0.0269675927420458 |
| cell cortex part (GO:0044448) | 0.027596038101769 |
| regulation of protein amino acid phosphorylation (GO:0001932) | 0.027596038101769 |
| nuclear transport (GO:0051169) | 0.0276295925051144 |
| wound healing (GO:0042060) | 0.0276295925051144 |
| metal ion homeostasis (GO:0055065) | 0.0282177299878462 |
| cellular metal ion homeostasis (GO:0006875) | 0.0282177299878462 |
| establishment and/or maintenance of apical/basal cell polarity (GO:0035088) | 0.0301991975405364 |
| kinesin binding (GO:0019894) | 0.0301991975405364 |
| anchoring collagen (GO:0030934) | 0.0301991975405364 |
| Notch binding (GO:0005112) | 0.0301991975405364 |
| adult locomotory behavior (GO:0008344) | 0.0304253230556742 |
| morphogenesis of a branching structure (GO:0001763) | 0.0304253230556742 |
| protein amino acid N-linked glycosylation (GO:0006487) | 0.0311329471966544 |
| protein targeting (GO:0006605) | 0.0313007417133229 |
| Golgi-associated vesicle (GO:0005798) | 0.031849201840849 |
| cellular protein complex assembly (GO:0043623) | 0.031849201840849 |
| regulation of amine metabolic process (GO:0033238) | 0.031849201840849 |
| gland development (GO:0048732) | 0.031849201840849 |
| regulation of amino acid metabolic process (GO:0006521) | 0.031849201840849 |
| aging (GO:0007568) | 0.032965252786912 |
| negative regulation of cell adhesion (GO:0007162) | 0.032965252786912 |
| axoneme (GO:0005930) | 0.0330148707729489 |
| fatty acid beta-oxidation (GO:0006635) | 0.0330148707729489 |
| heterochromatin (GO:0000792) | 0.0330148707729489 |
| clathrin coat of endocytic vesicle (GO:0030128) | 0.0330148707729489 |
| gonadotropin secretion (GO:0032274) | 0.0330148707729489 |
| perikaryon (GO:0043204) | 0.0330148707729489 |
| protein phosphatase type 2A activity (GO:0000158) | 0.0330148707729489 |
| epithelial cell development (GO:0002064) | 0.0330148707729489 |
| basal body (GO:0005932) | 0.0330148707729489 |
| regulation of telomere maintenance (GO:0032204) | 0.0330148707729489 |
| clathrin-coated endocytic vesicle membrane (GO:0030669) | 0.0330148707729489 |
| establishment of cell polarity (GO:0030010) | 0.0330148707729489 |
| histone acetyltransferase binding (GO:0035035) | 0.0330148707729489 |
| positive regulation of actin filament polymerization (GO:0030838) | 0.0330148707729489 |
| positive regulation of protein catabolic process (GO:0045732) | 0.0330148707729489 |
| postsynaptic density (GO:0014069) | 0.0330148707729489 |
| glial cell migration (GO:0008347) | 0.0330148707729489 |
| AP-2 adaptor complex (GO:0030122) | 0.0330148707729489 |
| superoxide release (GO:0042554) | 0.0330148707729489 |
| follicle-stimulating hormone secretion (GO:0046884) | 0.0330148707729489 |
| neurotrophin binding (GO:0043121) | 0.0330148707729489 |
| androgen biosynthetic process (GO:0006702) | 0.0330148707729489 |
| phosphatidylinositol-4,5-bisphosphate binding (GO:0005546) | 0.0330148707729489 |
| GTP-Rho binding (GO:0017049) | 0.0330148707729489 |
| T-tubule (GO:0030315) | 0.0330148707729489 |
| vacuolar membrane (GO:0005774) | 0.0330802238366008 |
| protein oligomerization (GO:0051259) | 0.0330802238366008 |
| Ras GTPase binding (GO:0017016) | 0.0330802238366008 |
| endocrine system development (GO:0035270) | 0.0353996699299574 |
| erythrocyte differentiation (GO:0030218) | 0.0353996699299574 |
| small GTPase regulator activity (GO:0005083) | 0.0393287335225518 |
| intracellular receptor-mediated signaling pathway (GO:0030522) | 0.0394509241761092 |
| positive regulation of protein amino acid phosphorylation (GO:0001934) | 0.0394509241761092 |
| positive regulation of amine metabolic process (GO:0033240) | 0.0394509241761092 |
| positive regulation of amino acid metabolic process (GO:0045764) | 0.0394509241761092 |
| sterol binding (GO:0032934) | 0.0394509241761092 |
| negative regulation of adenylate cyclase activity (GO:0007194) | 0.0397098676998532 |
| negative regulation of cyclase activity (GO:0031280) | 0.0397098676998532 |
| phorbol ester receptor activity (GO:0001565) | 0.0397098676998532 |
| skeletal morphogenesis (GO:0048705) | 0.0397098676998532 |
| protein kinase C activity (GO:0004697) | 0.0397098676998532 |
| placenta development (GO:0001890) | 0.0397098676998532 |
| negative regulation of lyase activity (GO:0051350) | 0.0397098676998532 |
| epidermis development (GO:0008544) | 0.0399557783148785 |
| Rho guanyl-nucleotide exchange factor activity (GO:0005089) | 0.0399557783148785 |
| trans-Golgi network (GO:0005802) | 0.0399557783148785 |
| collagen metabolic process (GO:0032963) | 0.0399557783148785 |
| actomyosin structure organization and biogenesis (GO:0031032) | 0.0399557783148785 |
| GTPase regulator activity (GO:0030695) | 0.0399557783148785 |
| cytokinesis (GO:0000910) | 0.0399557783148785 |
| gap junction (GO:0005921) | 0.0399557783148785 |
| regulation of endocytosis (GO:0030100) | 0.0399557783148785 |
| focal adhesion (GO:0005925) | 0.0399557783148785 |
| regulation of myeloid cell differentiation (GO:0045637) | 0.0399557783148785 |
| chromatin remodeling complex (GO:0016585) | 0.0399557783148785 |
| ER-nuclear sterol response pathway (GO:0030967) | 0.0399557783148785 |
| purine nucleotide transport (GO:0015865) | 0.0399557783148785 |
| purine nucleoside transmembrane transporter activity (GO:0015211) | 0.0399557783148785 |
| glial cell line-derived neurotrophic factor receptor activity (GO:0016167) | 0.0399557783148785 |
| regulation of oligodendrocyte differentiation (GO:0048713) | 0.0399557783148785 |
| dopamine receptor, adenylate cyclase inhibiting pathway (GO:0007195) | 0.0399557783148785 |
| tubulin deacetylase activity (GO:0042903) | 0.0399557783148785 |
| calcium-dependent protein serine/threonine phosphatase activity (GO:0004723) | 0.0399557783148785 |
| beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity (GO:0047223) | 0.0399557783148785 |
| protein-methionine-R-oxide reductase activity (GO:0000318) | 0.0399557783148785 |
| muscle cell migration (GO:0014812) | 0.0399557783148785 |
| zonula adherens (GO:0005915) | 0.0399557783148785 |
| hydrogen ion channel activity (GO:0015252) | 0.0399557783148785 |
| succinate metabolic process (GO:0006105) | 0.0399557783148785 |
| glutamate decarboxylase activity (GO:0004351) | 0.0399557783148785 |
| syntrophin complex (GO:0016013) | 0.0399557783148785 |
| procollagen N-endopeptidase activity (GO:0017074) | 0.0399557783148785 |
| negative regulation of T-helper cell differentiation (GO:0045623) | 0.0399557783148785 |
| transport accessory protein activity (GO:0015460) | 0.0399557783148785 |
| cell wall (GO:0005618) | 0.0399557783148785 |
| ATP transport (GO:0015867) | 0.0399557783148785 |
| ferrous iron binding (GO:0008198) | 0.0399557783148785 |
| activin receptor complex (GO:0048179) | 0.0399557783148785 |
| morphogenesis of an epithelial sheet (GO:0002011) | 0.0399557783148785 |
| O-glycan processing (GO:0016266) | 0.0399557783148785 |
| metallocarboxypeptidase D activity (GO:0008472) | 0.0399557783148785 |
| oxysterol binding (GO:0008142) | 0.0399557783148785 |
| negative regulation of T-helper 2 cell differentiation (GO:0045629) | 0.0399557783148785 |
| gap junction assembly (GO:0016264) | 0.0399557783148785 |
| glutamate secretion (GO:0014047) | 0.0399557783148785 |
| posterior compartment specification (GO:0007388) | 0.0399557783148785 |
| anterior compartment specification (GO:0007387) | 0.0399557783148785 |
| neural nucleus development (GO:0048857) | 0.0399557783148785 |
| myoblast migration (GO:0051451) | 0.0399557783148785 |
| collagen type XI (GO:0005592) | 0.0399557783148785 |
| positive regulation of Notch signaling pathway (GO:0045747) | 0.0399557783148785 |
| inhibin beta-A binding (GO:0048186) | 0.0399557783148785 |
| glutamate decarboxylation to succinate (GO:0006540) | 0.0399557783148785 |
| adenine nucleotide transport (GO:0051503) | 0.0399557783148785 |
| purine nucleoside transport (GO:0015860) | 0.0399557783148785 |
| striatum development (GO:0021756) | 0.0399557783148785 |
| L-serine transmembrane transporter activity (GO:0015194) | 0.0399557783148785 |
| serine transmembrane transporter activity (GO:0022889) | 0.0399557783148785 |
| regulation of Rho protein signal transduction (GO:0035023) | 0.0399557783148785 |
| desmosome (GO:0030057) | 0.040799439579907 |
| eukaryotic translation initiation factor 4F complex (GO:0016281) | 0.040799439579907 |
| negative regulation of cell-cell adhesion (GO:0022408) | 0.040799439579907 |
| pancreas development (GO:0031016) | 0.040799439579907 |
| L-amino acid transport (GO:0015807) | 0.040799439579907 |
| myoblast maturation (GO:0048628) | 0.040799439579907 |
| collagen fibril organization (GO:0030199) | 0.040799439579907 |
| endoplasmic reticulum lumen (GO:0005788) | 0.043245022423225 |
| vacuolar part (GO:0044437) | 0.043245022423225 |
| neurotransmitter binding (GO:0042165) | 0.0440543061733593 |
| vacuole (GO:0005773) | 0.044301942273629 |
| tissue morphogenesis (GO:0048729) | 0.0460395426063537 |
| lung development (GO:0030324) | 0.046170147357717 |
| histone methyltransferase activity (GO:0042054) | 0.046541355296619 |
| O-acyltransferase activity (GO:0008374) | 0.046541355296619 |
| protein phosphatase regulator activity (GO:0019888) | 0.0475669213005182 |
| protein import into nucleus, translocation (GO:0000060) | 0.0488047826520533 |
| heart morphogenesis (GO:0003007) | 0.0491648054895114 |
| striated muscle cell differentiation (GO:0051146) | 0.0491648054895114 |
| neurotransmitter biosynthetic process (GO:0042136) | 0.0491648054895114 |
| peptidyl-amino acid modification (GO:0018193) | 0.0499457299176201 |
